R.N. Girotra
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Pharmacology and Obesity Treatment, Pharmacological Effects and Assays, Nitric Oxide and Endothelin Effects
Most-Cited Works
- → Biphenylsulfonamide Endothelin Antagonists: Structure−Activity Relationships of a Series of Mono- and Disubstituted Analogues and Pharmacology of the Orally Active Endothelin Antagonist 2‘-Amino-N- (3,4-dimethyl-5-isoxazolyl)-4‘-(2-methylpropyl)[1,1‘-biphenyl]-2-sulfonamide (BMS-187308)(1998)40 cited
- → Beta 3 agonists. Part 1: evolution from inception to BMS-194449(2001)19 cited
- → BMS-196085: A potent and selective full agonist of the human β3 adrenergic receptor(2001)17 cited
- → BMS-201620: a selective beta 3 agonist(2004)16 cited
- → Arylpropanolamines: Selective β3 agonists arising from strategies to mitigate phase I metabolic transformations(2007)5 cited
- → ChemInform Abstract: Synthesis and Herbicidal Activity of Dihydropyrano(2,3‐b) pyridylimidazolinones and Related Compounds(1991)
- → ChemInform Abstract: Mercaptoacyl Dipeptides as Dual Inhibitors of Angiotensin‐Converting Enzyme and Neutral Endopeptidase. Preliminary Structure‐Activity Studies.(1995)